Algorithm for Investigation of Fabry Disease in Cardiomyopathies
Abstract Fabry disease (FD) is a rare, x-linked lysosomal storage disease caused by mutations in the GLA gene that leads to total or partial alfa galactosidase A deficiency. Its prevalence ranges between 1:117,000 and 1:8,454. Mutations in the GLA gene result in alpha galactosidase A deficiency lead...
Saved in:
| Main Authors: | Sandra Marques e Silva, Ândrea V. F. Chaves, Murillo O. Antunes, Natalia R. Roque, Eduarda M. S. Montenegro, Isabelle Malbouisson, Maurício A. de Paula, Edileide B. Correia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SciELO
2024-10-01
|
| Series: | Journal of Inborn Errors of Metabolism and Screening |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942024000100402&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction
by: Natsuko Inagaki, et al.
Published: (2025-03-01) -
The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy
by: B.M. Todurov, et al.
Published: (2020-12-01) -
Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study
by: Zongwei Lin, et al.
Published: (2024-12-01) -
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response
by: Anjali T. Owens, et al.
Published: (2024-09-01) -
Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Sarala Raj Murthi, et al.
Published: (2025-01-01)